Inclusive of all taxes
Cefotaxime Sodium for Injection 250 mg is a potent third-generation cephalosporin antibiotic specifically formulated as a sterile dry powder for injection. Each vial contains 250 mg of Cefotaxime Sodium, which, upon reconstitution, can be administered intravenously (IV) or intramuscularly (IM) to treat a broad spectrum of bacterial infections. It is highly effective against both Gram-positive and Gram-negative bacteria, working by inhibiting bacterial cell wall synthesis, ultimately resulting in bacterial cell death. This makes it suitable for the treatment of respiratory tract infections, urinary tract infections, skin infections, abdominal infections, septicemia, and other serious bacterial infections requiring hospital-based management. Cefotaxime Sodium 250 mg injection is especially recommended in clinical settings due to its rapid bactericidal activity and reliable efficacy even against beta-lactamase-producing strains. The powder formulation ensures stability and a longer shelf life before reconstitution, making it a practical choice for healthcare providers seeking a powerful and versatile antibiotic for injectable use.
Key Features
| Features | Description |
|---|---|
| Form | Sterile dry powder for injection |
| Strength | 250 mg Cefotaxime Sodium per vial |
| Route of Administration | Intravenous (IV) or Intramuscular (IM) injection |
| Spectrum | Broad spectrum activity against Gram-positive and Gram-negative bacteria |
| Mechanism of Action | Inhibits bacterial cell wall synthesis leading to bacterial cell death |
| Indications | Treatment of respiratory, urinary tract, skin, abdominal infections, and septicemia |
| Usage | Hospital and clinical setting use for serious bacterial infections |
| Stability | Stable dry powder form ensures long shelf life before reconstitution |
| Attributes | Description |
|---|---|
| Active Ingredient | Cefotaxime Sodium |
| Dosage Strength | 250 mg per vial |
| Physical Form | Sterile dry powder |
| Reconstitution Required | Yes, prior to administration |
| Injection Route | Intravenous (IV) or Intramuscular (IM) |
| Packaging | Single vial sterile packaging |
| Storage Conditions | Store in a cool, dry place protected from light |
| Therapeutic Class | Third-generation cephalosporin antibiotic |
| Shelf Life | Typically 24 months from manufacture when stored properly |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Yes, Cefotaxime Sodium 250 mg injection is designed for both intravenous and intramuscular administration after proper reconstitution.
Yes, this third-generation cephalosporin antibiotic has efficacy against many beta-lactamase producing bacterial strains.
The product should be stored in a cool, dry place protected from light to maintain stability and efficacy.
No, it is supplied as a sterile dry powder that must be reconstituted with an appropriate diluent before use.
It is effective in treating respiratory tract infections, urinary tract infections, skin and soft tissue infections, abdominal infections, and septicemia caused by susceptible organisms.
Cefotaxime Sodium for Injection 250 mg is a third-generation cephalosporin antibiotic used to treat a variety of bacterial infections. It is effective against a broad spectrum of Gram-positive and Gram-negative bacteria.
Key Features:
Form: Dry powder for injection.
Strength: 250 mg of Cefotaxime Sodium.
Route of Administration: Intravenous (IV) or intramuscular (IM).
Mechanism of Action: Cefotaxime inhibits bacterial cell wall synthesis, causing bacterial cell death.
Inclusive of all taxes
You Save: 0
